Dynavax to Present at Two Upcoming Investor Conferences

/PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative...

Related Keywords

Derek Cole ,Ryan Spencer ,Kelly Macdonald ,Nicole Arndt ,European Union ,Investor Relations Advisory Solutions ,Securities Exchange ,Company Quarterly Report On Form ,Dynavax Technologies Corporation Nasdaq ,Dynavax Technologies Corporation ,Chief Executive Officer ,Chief Financial Officer ,Healthcare Talks ,Annual Immunology ,Annual Evercore ,Securities Act ,Securities Exchange Act ,Quarterly Report ,Dynavax Technologies ,